Dou Yeon Youn

1.7k citations
13 papers · 1.3k indexed · 1 hit paper · h-index 11
Topics
Sirtuins and Resveratrol in Medicine (4 papers)Adipose Tissue and Metabolism (4 papers)Ubiquitin and proteasome pathways (3 papers)

In The Last Decade

Dou Yeon Youn

13 papers receiving 1.3k citations

Hit Papers

The NAD+ Precursor Nicotinamide Riboside Enhances Oxidati...20122026201620212012250500750

Peers

Dou Yeon Youn
Comparison fields: 5 of 88
  • Geriatrics and Gerontology 632
  • Molecular Biology 497
  • Physiology 444
  • Epidemiology 347
  • Oncology 271
Replace Karthikeyani Chellappa with:
Karthikeyani Chellappa United States
David W. Frederick United States
Marie Boutant Switzerland
J. Daniel Pennington United States
Andrew A. Grimm United States
Ralph R. Alcendor United States
Myeong Jin Yoon United States
Joanna Ratajczak Switzerland
Cristina Travelli Italy
Kristin E. Dittenhafer‐Reed United States
Dou Yeon Youn relative to Karthikeyani Chellappa United States Karthikeyani Chellappa's profile →
Citations per field
00.5×4.2×
Karthikeyani Chellappa · 1×
Citations per year

Countries citing papers authored by Dou Yeon Youn

Since Specialization
Citations

This map shows the geographic impact of Dou Yeon Youn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dou Yeon Youn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dou Yeon Youn more than expected).

Fields of papers citing papers by Dou Yeon Youn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dou Yeon Youn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dou Yeon Youn. The network helps show where Dou Yeon Youn may publish in the future.

Co-authorship network of co-authors of Dou Yeon Youn

This figure shows the co-authorship network connecting the top 25 collaborators of Dou Yeon Youn. A scholar is included among the top collaborators of Dou Yeon Youn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dou Yeon Youn. Dou Yeon Youn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 8
2 1
3 11
4 12
5 16
6 15
7 26
8 61
9
The NAD+ Precursor Nicotinamide Riboside Enhances Oxidative Metabolism and Protects against High-Fat Diet-Induced Obesitybreakdown →
945
10 81
11 55
12 93
13 22

About Dou Yeon Youn

Dou Yeon Youn is a scholar working on Geriatrics and Gerontology, Physiology and Physiology, having authored 13 papers that have together received 1.3k indexed citations. Recurring topics across this work include Sirtuins and Resveratrol in Medicine (4 papers), Adipose Tissue and Metabolism (4 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Geriatrics and Gerontology (632 citations), Physiology (268 citations) and Aging (58 citations). Dou Yeon Youn has collaborated with scholars based in United States, Switzerland and Finland. Frequent co-authors include Anthony A. Sauve, Yana Cen, Pablo J. Fernández-Marcos, Kristina Schoonjans, Chris Rinsch, Riekelt H. Houtkooper, Maaike H. Oosterveer, Pénélope A. Andreux, Carles Cantó and Hiroyasu Yamamoto. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Cell Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026